Last reviewed · How we verify
STEM-OA
At a glance
| Generic name | STEM-OA |
|---|---|
| Sponsor | StemMedical A/S |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Development of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions (NA)
- The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis (PHASE2)
- Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA (PHASE1)
- EMG Analysis in ABI: Motor Imagery and Action (NA)
- Impact of Mesenchymal Stem Cells in Knee Osteoarthritis (PHASE1)
- A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis (PHASE2)
- Physiological Impact of Different Types of Osteoarthritis Education. (NA)
- A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- STEM-OA CI brief — competitive landscape report
- STEM-OA updates RSS · CI watch RSS
- StemMedical A/S portfolio CI